The S Health is a mobile application intended for use in home to help people in reviewing and monitoring vital signs such as non-invasive blood pressure, blood glucose, weight and other data from optional add-on devices for effective health management. The user also can share the data via sharing functions (Email and SMS).

Device Description

The S Health is application software for mobile device. This mobile application helps users to care their personal health better by recording and displaying information such as comfort level(temperature and humidity), step count (pedometer), how much user exercises (calories burnt), the food user may consume (calories intake), weight, blood glucose level, and blood pressure in an effective and user friendly interface.

AI/ML Overview

Here's an analysis of the provided text regarding the acceptance criteria and study for the "S Health" device:

Acceptance Criteria and Reported Device Performance

The provided 510(k) summary for the "S Health" device does not explicitly list quantitative acceptance criteria in a table format. Instead, it describes two types of performance evaluations:

Data Accuracy Transmission: This involved testing the accuracy of data transmission for each meter (blood pressure, blood glucose, weight) and memory data rollover.
Lay User Performance/Satisfaction: This assessed how easy the S Health application was to use for lay users and their overall satisfaction.

Based on the text, here's a representation of the acceptance criteria (inferred from the study results) and the reported device performance.

Acceptance Criteria (Inferred)	Reported Device Performance
Accurate transmission of measurement values, data, and time	"Test results show that all the measurement values, data, and time properly downloaded from the meters to the software."
Proper functioning of memory data rollover	"Memory data rollover also functioned properly where the new measurement values replaced the oldest glucose values."
High level of ease of use for lay users	"Overall, they rated the S Health at 100% for overall program as easy or somewhat easy. There were no users that rated the software program as somewhat difficult or difficult."
High level of satisfaction among lay users with the S Health and its manual	"100% of them also responded that they are satisfied with the S Health and its manual."

Study Details

Sample size used for the test set and the data provenance:
- Sample Size: The document does not specify the exact number of lay users who participated in the human factors/usability study. It only states "a study intended to assess lay users' performance."
- Data Provenance: The document does not specify the country of origin of the data. The study appears to be prospective, as it involved conducting a study to assess user performance.
Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- The document does not mention the use of experts to establish ground truth for the "lay user performance" study. The ground truth for this study appears to be the users' self-reported ease of use and satisfaction.
- For the data transmission accuracy tests, the "ground truth" would implicitly be the readings on the meters themselves, verified against the data received by the software. No specific number of experts or their qualifications are mentioned for this bench testing.
Adjudication method for the test set:
- Not applicable for the described tests. The data transmission accuracy was a direct comparison, and the user performance was based on self-reported ratings.
If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- No, a multi-reader multi-case (MRMC) comparative effectiveness study was not done. The S Health is a data management application and not an AI-powered diagnostic tool requiring such a study.
If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
- The "bench testing to demonstrate data accuracy transmission for each meter" could be considered a standalone performance evaluation of the application's ability to receive and display data correctly, without human interpretation of the data itself. However, the application's intended use is to help users review and monitor vital signs, implying a human-in-the-loop for the monitoring aspect.
The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
- For data accuracy transmission: The ground truth was the direct measurements from the connected medical devices (blood pressure monitor, blood glucose meter, weight scale).
- For lay user performance: The ground truth was the users' self-reported ratings of ease of use and satisfaction.
The sample size for the training set:
- The document does not describe any machine learning or AI components that would require a separate training set. The S Health is described as a "mobile application" that records and displays information.
How the ground truth for the training set was established:
- Not applicable, as no training set for a machine learning model is mentioned.

Summary

{0}------------------------------------------------

510(k) Summary

This summary of 510(k)-safety and effectiveness information is being submitted in accordance with requirements of 21 CFR Part 807.92.

Date:

Applicant / Submitter: 1.

Samsung Electronics Co., Ltd. 129, Samsung-ro. Yeongtong-gu. Suwon-si. Republic of Korea 443-742

DEC 0 4 2013

Tel : +82-31-301-7374 Fax : +82-31-301-1768

Submission Correspondent: 2.

Priscilla Chung LK Consulting Group USA. Inc. 1515 E. Katella Ave. Unit 2115. Anaheim, CA 92805 Phone: 714-202-5789. Fax: 714-409-3357 Email: juhee.c@lkconsultinggroup.com

Device: 3.

Proprietary Name:	S Health
Common Name:	Healthcare Data Management Mobile Application
Classification Name:	Transmitters And Receivers, Physiological Signal,RadiofrequencySystem, Measurement, Blood-Pressure, Non-InvasiveSystem, Test, Blood Glucose, Over The CounterScale, Stand-On, Patient
Classification:	Class II,21 CFR 870.291021 CFR 870.113021 CFR 862.134521 CFR 880.2700
Classification Product Code:	DRG, DXN, NBW, FRI

{1}------------------------------------------------

K132148 Page 2 of 3

4. Predicate Device:

MedApps 2.0 - Remote Patient Monitoring System (K083862) by MedApps, Inc. Ambio Remote Health Monitoring System (K130676) by Arrayent Health LLC /dba Ambio Health

Apps-Health01 (K122098) by Andon Health Co., Ltd.

iBGStar Diabetes Manager Application (K130535) by AgaMatrix. Inc.

ર. Device Description:

ે. Intended Use:

7. Performance Data(Non-Clinical):

Samsung Electronics Co, Ltd. conducted bench testing to demonstrate data accuracy transmission for each meter. Memory data rollover was also tested by adding ten (10) data points to meters that were pre-loaded with full memory. Test results show that all the measurement values, data, and time properly downloaded from the meters to the software. Memory data rollover also functioned properly where the new measurement values replaced the oldest glucose values.

In addition, a study intended to assess lay users' performance in using the S Health was conducted. Overall, they rated the S Health at 100% for overall program as easy or somewhat easy. There were no users that rated the software program as somewhat difficult or difficult. 100% of them also responded that they are satisfied with the S Health and its manual.

The study results supports that the S Health is effective and provides accurate data management system as other predicate devices in the market.

8. Substantial Equivalence

The predicate devices and S Health are optional software accessories for use with blood glucose, blood pressure, and weight with data management capability.

There are some minor differences between the subject device and the predicate device in software operation options, settings and some other features, but it does not constitute a new intended use. Despite the differences, the validation testing results presented in this 510K supports that the S Health is safe and effective as the predicate devices.

{2}------------------------------------------------

K132148 Page 3 of 3

. .

9. Conclusion:

Based on the testing results. Samsung Electronics concludes that the S Health is safe and effective also, substantially equivalent to the predicate devices.

1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 - 1999 -

. .

{3}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

Image /page/3/Picture/11 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes coiled around it. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the caduceus symbol. The logo is black and white.

December 4, 2013

Samsung Electronic Con. Ltd. % Priscilla Chung Official Correspondent LK Consulting Group 1515 E Katella Ave. Unit 2115 Anaheim, CA 92805 US

Re: K132148 Trade/Device Name: S Health Regulation Number: 21 CFR 870.2910 Regulation Name: Healthcare Data Management Mobile Application Regulatory Class: Class II Product Code: DRG, NBW, DXN, FRI Dated: November 4, 2013 Received: November 7, 2013

Dear Priscilla Chung:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28. 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act

{4}------------------------------------------------

Page 2 - Priscilla Chung

or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDeyices/ResourcesforYou/Industry/default.htm.

Sincerely yours.

Owen P. Faris -S

for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

Indications for Use

510(k) Number: K _

Device Name: S Health

Indication for use:

Prescription Use_ (Part 21CFR801 Subpart D)

AND/OR

Over-The-Counter Use (Part 21CFR807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Regulation Number and Section

§ 870.2910 Radiofrequency physiological signal transmitter and receiver.

(a)
Identification. A radiofrequency physiological signal transmitter and receiver is a device used to condition a physiological signal so that it can be transmitted via radiofrequency from one location to another, e.g., a central monitoring station. The received signal is reconditioned by the device into its original format so that it can be displayed.(b)
Classification. Class II (performance standards).